The STAR™ Tumor Ablation Registry

The STAR™ Tumor Ablation Registry

Registry collecting data on use of The STAR™ Tumor Ablation System.

The STAR Prospective Registry is an observational registry to gather clinical safety and outcome data in patients with painful spinal metastases in the thoracolumbar spine (T1-L5) following targeted radiofrequency ablation (t-RFA) treatment with the STAR™ Tumor Ablation System.

Inclusion Criteria:

• Subjects with painful spinal metastatic lesions in thoracolumbar vertebrae (T1-L5) that will be treated with t-RFA using the STAR™ Tumor Ablation System.
• Have signed informed consent

Exclusion Criteria:

• Subjects under 18 years old
• Subjects with heart pacemakers, or other electronic device implants
• Subjects intended for t-RFA in vertebral body levels C1-7